Compare Canopy Growth Corp (CGC) vs Lowe`s Companies Inc (LOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs Lowe`s Companies Inc — how do they compare? Canopy Growth Corp trades at $1.04 (market cap $421.10M), while Lowe`s Companies Inc trades at $216.34 (market cap $124.06B). The key difference: Lowe`s Companies Inc is far larger — about 294.6× Canopy Growth Corp's market cap, and Lowe`s Companies Inc pays a 2.26% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | LOW | |
|---|---|---|
Market Cap | $421.10M | $124.06B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.92 | $287.39 |
52-Week Low | $0.86 | $201.92 |
Enterprise Value | $378.55M | $165.81B |
Dividend Yield | — | 2.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
Lowe's (LOW) trades at $216.14, down 1.23% with a bullish technical outlook supported by moving averages. The company maintains solid fundamentals with consistent earnings beats and a 7.51% net margin, though revenue declined to $83.67B in 2025. Analyst consensus remains strongly positive with a $257.06 price target and 61% buy ratings. Recent news highlights upcoming Q2 2026 earnings and community investments.
LOW presents a compelling investment case with strong analyst support and stable cash flows, but faces risks from competitive pressures and declining revenue trends. The stock's current valuation at 18.7x P/E appears reasonable given earnings consistency, though investors should monitor same-store sales performance in the upcoming earnings report.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →
